Skip to main content

Table 1 Improved liver function of patients after bone marrow-derived stem cells (BMSCs) transplantation

From: Bone marrow-derived stem cells ameliorate hepatic fibrosis by down-regulating interleukin-17

Index

Weeks

Baseline

4w

12w

24w

36w

48w

Albumin(g/L)

29.25(3.80)

34.83(4.87)*

35.98(4.36)*

40.03(5.42)*

38.11(5.28)*

39.27(6.65)*

PTA(%)

51.50(15.51)

61.46(17.80)*

64.23(13.45)*

72.17(14.05)*

69.40(11.37)*

62.91(13.42)*

CHE(U/L)

2766.43(913.79)

3527.94(1113.25)*

3625.55(1150.36)*

4168.91(1403.57)*

4438.27(1032.26)*

4902.87(1771.91)*

CTP score

9.05(1.94)

7.25(1.98)*

7.03(2.16)*

6.45(1.60)*

6.52(1.93)*

6.64(1.69)*

MELD score

14.04(4.89)

12.09(3.31)*

11.33(4.60)*

10.34(4.93)*

10.40(4.09)*

10.52(6.36)*

  1. Values are expressed as the mean (standard deviation).
  2. *p < 0.05 in comparison with baseline. Baseline, 1 week before transplantation.
  3. PTA, prothrombin activity; CHE, cholinesterase; CTP, Child-Turcotte-Pugh; MELD, Model for End-Stage Liver Disease.
Back to article page

Cell & Bioscience

ISSN: 2045-3701

Contact us